相关实验视频

Updated: May 5, 2026

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

S-Adenosyl-l-methionine恢复大脑线粒体膜流动性和GSH含量,改善尼曼-皮克C型疾病

Leire Goicoechea¹, Sandra Torres¹, Laura Fàbrega¹

¹Department of Cell Death and Proliferation, Institute of Biomedical Research of Barcelona (IIBB), CSIC, Barcelona, Spain; Liver Unit, Hospital Clinic I Provincial de Barcelona, Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red (CIBEREHD), Barcelona, Spain.

|April 10, 2024

概括

补充S-Adenosyl-l-methionine (SAM) 改善了线粒体功能,并在Niemann-Pick型C (NPC) 疾病小鼠模型中延长了寿命. 这项研究突出了SAM的重点.

科学领域:

生物化学生化学
神经科学是一个神经科学.
遗传学是一个遗传学.

背景情况:

尼曼-皮克C型疾病 (NPC) 是一种溶酶体储存障碍,导致神经缺陷和运动障碍.
在NPC疾病中,胆固醇的积累会影响线粒体,减少膜流动性,损害功能和耗尽谷氨 (GSH).
S-Adenosyl-l-methionine (SAM) 影响膜特性和GSH合成,但其在NPC疾病中的作用尚不清楚.

研究的目的:

调查SAM在NPC疾病病原发生中的作用.
在尼曼-皮克C型小鼠模型中评估SAM的治疗潜力.

主要方法:

在Npc1-/-小鼠中评估大脑SAM水平和线粒体功能.
分析了线粒体PC/PE比率和GSH水平,使用液体染色学高分辨率质谱.
在体内给Npc1-/-小鼠注射SAM并评估运动活性,普金尼细胞存活率和寿命.

主要成果:

Npc1-/-小鼠显示脑SAM水平降低和线粒体PC/PE比率降低,表明膜秩序增加.
在体内SAM治疗恢复了线粒体SAM,增加了PC/PE比率,改善了膜流动性,并补充了GSH水平.
在Npc1-/-小鼠中,SAM治疗改善了运动缺陷,增强了普金尼细胞存活率,并延长了寿命.

结论:

降低SAM水平有助于NPC疾病中的线粒体功能障碍.
补充SAM是一种有前途的治疗策略,用于尼曼-皮克C型疾病.
恢复线粒体SAM水平可以逆转关键的病理特征,改善NPC疾病的结果.

关键词:

抗氧化剂抗氧化剂是一种抗氧化剂.膜流动性膜流动性线粒体GSH是一种线粒体GSH.神经退行发生神经退行.

更多相关视频

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)

Published on: January 10, 2025

相关概念视频

Hepatic Encephalopathy

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...